Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsEPIDURALGeneric

DEPODUR

MORPHINE SULFATE

Standard Dose
20MG/2ML (10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DEPODUR is listed in Drugs@FDA under application 021671 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MORPHINE SULFATE Form and strength INJECTABLE, LIPOSOMAL;EPIDURAL - 20MG/2ML (10MG/ML) Sponsor PACIRA PHARMS INC Submission history Latest submission status date: 2009-09-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview DEPODUR is listed in Drugs@FDA under application 021671 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MORPHINE SULFATE Form and strength INJECTABLE, LIPOSOMAL;EPIDURAL - 20MG/2ML (10MG/ML) Sponsor PACIRA PHARMS INC Submission history Latest submission status date: 2009-09-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.